Dark

KALA
KALA BIO, Inc. Common Stock
stock NASDAQ

At Close

Dec 11, 2025 3:59:30 PM EST

0.6832USD-11.261%(-0.0867)2,815,170

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Dec 11, 2025 9:28:30 AM EST

0.7543USD-2.026%(-0.0156)145,256

After-hours

Dec 11, 2025 4:56:30 PM EST

0.7097USD+3.879%(+0.0265)61,999

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

7.34M

CEO

Mark Iwicki

Headquarters

Watertown, Massachusetts, USA

Industry

Drug Manufacturers-Specialty & Generic

Last Split

Oct 21, 20221for50reverse

OMER XLV

KALA Stats

Avg. Vol. 10 Day

41,948,284

Avg. Vol. 30 Day

14,188,865

Employees

Market Cap

7,339,132

Shares Out.

10,729,725

On/Off Exchange

44%/56%

6 Month Beta

1.14

1 Year Beta

1.14

2 Year Beta

0.92

3 Year Beta

0.99

52 Week Low

0.61

52 Week High

20.60

SMA50

0.98

SMA200

5.44

1 Week

-29.05%

1 Month

-8.25%

3 Month

-95.98%

6 Month

-84.38%

1 Year

-88.99%

2 Year

-90.55%

5 Year

-99.82%

Profile

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala's website at www.kalarx.com.

KALA Stock Summary

KALA BIO, Inc. Common Stock (NASDAQ:KALA) stock price today is $0.6832, and today's volume is 2,815,170. KALA is down -11.261% today. The 30 day average volume is 14,188,865. KALA market cap is 7.34M with 10,729,725 shares outstanding.